Roche Loses Last Shot At Booting NJ Accutane Judge
Law360, New York (January 14, 2014, 4:31 PM EST) -- The New Jersey Supreme Court on Tuesday stamped out Hoffmann-La Roche Ltd.'s attempt to expel the presiding trial judge from consolidated litigation alleging personal injuries from the company's acne drug Accutane.
In a brief order, the state's highest court denied Roche's request for leave to appeal Judge Carol Higbee's refusal to recuse herself from the underlying multicounty litigation, which comprises more than 7,700 lawsuits blaming Accutane for inflammatory bowel disease and other ailments.
Roche has now failed to convince three courts, including Judge Higbee herself, that her conduct warranted removal. The drugmaker had complained about comments she made to a defense...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!